Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC vs DISHMAN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC DISHMAN PHARMA ALEMBIC/
DISHMAN PHARMA
 
P/E (TTM) x 25.3 30.0 84.2% View Chart
P/BV x 0.7 3.3 22.3% View Chart
Dividend Yield % 2.5 0.7 372.9%  

Financials

 ALEMBIC   DISHMAN PHARMA
EQUITY SHARE DATA
    ALEMBIC
Mar-22
DISHMAN PHARMA
Mar-16
ALEMBIC/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs143374 38.3%   
Low Rs72129 55.9%   
Sales per share (Unadj.) Rs3.0197.0 1.5%  
Earnings per share (Unadj.) Rs3.421.2 15.8%  
Cash flow per share (Unadj.) Rs3.534.7 10.2%  
Dividends per share (Unadj.) Rs1.802.00 90.0%  
Avg Dividend yield %1.70.8 210.4%  
Book value per share (Unadj.) Rs97.2179.9 54.1%  
Shares outstanding (eoy) m256.7880.70 318.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x35.31.3 2,766.6%   
Avg P/E ratio x32.111.9 270.0%  
P/CF ratio (eoy) x30.47.3 418.7%  
Price / Book Value ratio x1.11.4 79.1%  
Dividend payout %53.69.4 568.2%   
Avg Mkt Cap Rs m27,64320,307 136.1%   
No. of employees `000NANA-   
Total wages/salary Rs m2155,355 4.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m78215,898 4.9%  
Other income Rs m892265 336.0%   
Total revenues Rs m1,67416,163 10.4%   
Gross profit Rs m1394,103 3.4%  
Depreciation Rs m491,091 4.5%   
Interest Rs m4944 0.4%   
Profit before tax Rs m9792,334 41.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m117624 18.7%   
Profit after tax Rs m8621,710 50.4%  
Gross profit margin %17.825.8 69.0%  
Effective tax rate %11.926.7 44.6%   
Net profit margin %110.210.8 1,024.5%  
BALANCE SHEET DATA
Current assets Rs m1,43311,018 13.0%   
Current liabilities Rs m6789,517 7.1%   
Net working cap to sales %96.69.4 1,023.2%  
Current ratio x2.11.2 182.7%  
Inventory Days Days10,34657 18,145.9%  
Debtors Days Days7103 20,309.4%  
Net fixed assets Rs m24,88618,787 132.5%   
Share capital Rs m514161 318.2%   
"Free" reserves Rs m24,45214,354 170.4%   
Net worth Rs m24,96614,516 172.0%   
Long term debt Rs m04,189 0.0%   
Total assets Rs m26,32029,805 88.3%  
Interest coverage x252.63.5 7,276.4%   
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x00.5 5.6%   
Return on assets %3.38.9 36.9%  
Return on equity %3.511.8 29.3%  
Return on capital %3.917.5 22.5%  
Exports to sales %2.024.9 8.0%   
Imports to sales %0.33.7 7.8%   
Exports (fob) Rs m163,956 0.4%   
Imports (cif) Rs m2594 0.4%   
Fx inflow Rs m164,952 0.3%   
Fx outflow Rs m2697 0.3%   
Net fx Rs m134,255 0.3%   
CASH FLOW
From Operations Rs m-1772,786 -6.4%  
From Investments Rs m188-1,529 -12.3%  
From Financial Activity Rs m-58-941 6.2%  
Net Cashflow Rs m-47317 -14.9%  

Share Holding

Indian Promoters % 70.9 61.4 115.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 5.0 23.0 21.6%  
FIIs % 0.8 12.0 6.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 38.6 75.4%  
Shareholders   83,612 52,291 159.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC With:   SUN PHARMA    CIPLA    DR. REDDYS LAB    LUPIN    ZYDUS LIFESCIENCES    


More on ALEMBIC vs Dishman Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ALEMBIC vs Dishman Pharma Share Price Performance

Period ALEMBIC Dishman Pharma S&P BSE HEALTHCARE
1-Day -0.27% 2.87% 0.23%
1-Month 2.40% -2.45% 0.36%
1-Year -27.39% 96.38% -6.87%
3-Year CAGR 11.12% 50.28% 20.16%
5-Year CAGR 12.07% 41.17% 11.07%

* Compound Annual Growth Rate

Here are more details on the ALEMBIC share price and the Dishman Pharma share price.

Moving on to shareholding structures...

The promoters of ALEMBIC hold a 70.9% stake in the company. In case of Dishman Pharma the stake stands at 61.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ALEMBIC and the shareholding pattern of Dishman Pharma.

Finally, a word on dividends...

In the most recent financial year, ALEMBIC paid a dividend of Rs 1.8 per share. This amounted to a Dividend Payout ratio of 53.6%.

Dishman Pharma paid Rs 2.0, and its dividend payout ratio stood at 9.4%.

You may visit here to review the dividend history of ALEMBIC, and the dividend history of Dishman Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Mark Mobius on Cryptos | Dharmaj Crop IPO Fully Subscribed on Debut | Top Buzzing Stocks Today(Pre-Open)

On Monday, Indian share markets hit new records following heavy gains from Reliance and other oil marketing companies as crude prices fell.